NCT04845685View on ClinicalTrials.gov

A Study to Evaluate Continuous Glucose Monitor in Hospitalized, Post-operative Patients With Diabetes Mellitus

NASuspendedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2026

Primary Completion Date

December 8, 2026

Study Completion Date

December 8, 2026

Conditions
Diabetes Mellitus
Interventions
DEVICE

Continuous Glucose Monitor (CGM)

A device that measures blood sugar levels every 1-5 minutes

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER